Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 568, pseudogene (RN7SL568P) is a human pseudogene corresponding to a non-functional, truncated copy of the 7SL RNA gene[4][1][8]. The 7SL RNA is a critical RNA component of the signal recognition particle (SRP), which functions in directing newly synthesized proteins to the endoplasmic reticulum membrane[5]. In the human genome, hundreds of 7SL RNA-like sequences exist, but the majority—including RN7SL568P—are pseudogenes generated by the retrotransposition or reverse transcription of the 7SL RNA and are incapable of producing functional SRP RNA or protein[6][7][1]. These pseudogenes typically do not have known coding capacity, regulator activity, disease association, or therapeutic targeting potential, and there are no known drugs or biomarker uses related to RN7SL568P specifically[1][8]. The approved symbol and full name are standardized by the HUGO Gene Nomenclature Committee[4]. As a pseudogene, RN7SL568P does not encode a functional protein or RNA and is considered a genomic remnant rather than an active molecular target[1][4][6]. Functional 7SL RNA contributes to the SRP complex and cotranslational protein targeting[5], but RN7SL568P and similar pseudogenes lack the sequence integrity for such roles[7]. While some pseudogenes modulate gene expression or participate in regulatory RNA networks, RN7SL568P has no reported such functions in available resources[1][7][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 568, pseudogene (RN7SL568P).